OMCL Omnicell, Inc.
Healthcare$44.38+0.00%OpenMarket Cap: $2.02B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$57.20
Target (Median)
$55.00
Target Range
$49.00 - $70.00
Upside from current price: 28.9%
Rating Distribution
1 Strong Buy6 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-29 | Keybanc | maintain | Overweight | Overweight |
| 2026-04-23 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-02-06 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-02 | Benchmark | maintain | Buy | Buy |
| 2026-01-08 | Keybanc | upgrade | Overweight | Sector Weight |
| 2026-01-05 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-12-09 | B of A Securities | maintain | Neutral | Neutral |
| 2025-12-09 | Benchmark | maintain | Buy | Buy |
| 2025-10-31 | Benchmark | maintain | Buy | Buy |
| 2025-08-11 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Dec 31 | $1.72 | $1.18B | 6 |
| Thu Dec 31 | $1.94 | $1.25B | 5 |
| Fri Dec 31 | $2.20 | $1.32B | 5 |
| Sun Dec 31 | $2.30 | $1.42B | 1 |